5631

0

PAR

img img img img
No Data Available

PAR DRUGS AND CHEM LTD Share Price Update

As of the latest trading session, PAR DRUGS AND CHEM LTD is trading at ₹93.25, up by ₹1.66 or 1.81% from its previous close. The stock has moved between ₹90.20 and ₹94.34 today. Over the past year, the stock has delivered a return of -8.15%. In the last month, it has returned 0.50%.

PAR DRUGS AND CHEM LTD performance

Today’s low Today’s high
₹ 90.20 ₹ 94.34
₹ 93.01
52 week low 52 week high
₹ 78.05 ₹ 122.43
₹ 93.01
Open Price ₹ 91.85
Prev. Close ₹ 91.58
Volume (Shares) 3989.00
Total traded value ₹ 3.71
Upper Circuit ₹ 109.89
Lower Circuit ₹ 73.27
info

Investment Returns

Over 1 Month 0.50% Over 3 Months -8.28% Over 6 Months -6.20% Over 1 Year -8.15%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PAR DRUGS AND CHEM LTD fundamentals


  • Market cap (Cr) 114.40
  • P/E Ratio (TTM) 8.10
  • Beta 0.95
  • Book Value / share 86.49
  • Return on equity 14.47%
  • EPS (TTM) 11.30
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 4.80
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

PAR DRUGS AND CHEM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 29.34
Operating Expense 24.22
Net Profit 4.80
Net Profit Margin (%) 16.35
Earnings Per Share (EPS) 3.90
EBITDA 7.38
Effective Tax Rate (%) 25.46
Particulars SEP 2025 (Values in Cr)
Revenue 28.66
Operating Expense 23.58
Net Profit 4.13
Net Profit Margin (%) 14.41
Earnings Per Share (EPS) 3.36
EBITDA 6.53
Effective Tax Rate (%) 25.58
Particulars JUN 2025 (Values in Cr)
Revenue 26.05
Operating Expense 23.41
Net Profit 3.33
Net Profit Margin (%) 12.78
Earnings Per Share (EPS) 2.70
EBITDA 5.40
Effective Tax Rate (%) 25.66
Particulars MAR 2025 (Values in Cr)
Revenue 22.33
Operating Expense 20.84
Net Profit 1.65
Net Profit Margin (%) 7.38
Earnings Per Share (EPS) 1.34
EBITDA 3.21
Effective Tax Rate (%) 27.63
Particulars DEC 2024 (Values in Cr)
Revenue 21.38
Operating Expense 20.88
Net Profit 0.58
Net Profit Margin (%) 2.71
Earnings Per Share (EPS) 0.47
EBITDA 1.69
Effective Tax Rate (%) 24.67
Particulars MAR 2025 (Values in Cr)
Revenue 100.97
Operating Expense 85.20
Net Profit 13.36
Net Profit Margin (%) 13.23
Earnings Per Share (EPS) 10.86
EBITDA 21.65
Effective Tax Rate (%) 25.50
Particulars MAR 2024 (Values in Cr)
Revenue 95.64
Operating Expense 76.37
Net Profit 14.50
Net Profit Margin (%) 15.16
Earnings Per Share (EPS) 11.78
EBITDA 23.07
Effective Tax Rate (%) 25.71
Particulars MAR 2023 (Values in Cr)
Revenue 95.75
Operating Expense 80.89
Net Profit 11.33
Net Profit Margin (%) 11.83
Earnings Per Share (EPS) 9.21
EBITDA 18.44
Effective Tax Rate (%) 24.86
Particulars MAR 2022 (Values in Cr)
Revenue 75.07
Operating Expense 62.55
Net Profit 9.21
Net Profit Margin (%) 12.26
Earnings Per Share (EPS) 7.49
EBITDA 16.43
Effective Tax Rate (%) 27.48
Particulars MAR 2021 (Values in Cr)
Revenue 60.75
Operating Expense 48.20
Net Profit 11.61
Net Profit Margin (%) 19.11
Earnings Per Share (EPS) 18.87
EBITDA 18.19
Effective Tax Rate (%) 21.11
Particulars MAR 2025 (Values in Cr)
Book Value / Share 80.44
ROE % 14.47
ROCE % 19.48
Total Debt to Total Equity 0.00
EBITDA Margin 19.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 69.59
ROE % 18.49
ROCE % 25.01
Total Debt to Total Equity 0.00
EBITDA Margin 21.50
Particulars MAR 2023 (Values in Cr)
Book Value / Share 57.90
ROE % 17.28
ROCE % 23.11
Total Debt to Total Equity 0.00
EBITDA Margin 19.26
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.66
ROE % 16.43
ROCE % 21.70
Total Debt to Total Equity 0.07
EBITDA Margin 19.36
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.87
ROE % 21.72
ROCE % 24.78
Total Debt to Total Equity 0.15
EBITDA Margin 23.45
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 27.57
Total Assets 119.39
Total Liabilities 119.39
Total Equity 98.97
Share Outstanding 1
Price to Book Ratio 1.06
Return on Assets (%) 11.18
Return on Capital (%) 13.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 36.65
Total Assets 101.61
Total Liabilities 101.61
Total Equity 85.63
Share Outstanding 1
Price to Book Ratio 3.10
Return on Assets (%) 14.27
Return on Capital (%) 16.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 22.24
Total Assets 88.86
Total Liabilities 88.86
Total Equity 71.23
Share Outstanding 1
Price to Book Ratio 2.42
Return on Assets (%) 12.75
Return on Capital (%) 15.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 16.20
Total Assets 78.69
Total Liabilities 78.69
Total Equity 59.87
Share Outstanding 1
Price to Book Ratio 3.28
Return on Assets (%) 11.70
Return on Capital (%) 15.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 21.16
Total Assets 76.38
Total Liabilities 76.38
Total Equity 52.21
Share Outstanding 0
Price to Book Ratio 1.46
Return on Assets (%) 15.20
Return on Capital (%) 19.4
Particulars MAR 2025 (Values in Cr)
Net Income 17.92
Cash from Operations 20.67
Cash from Investing -25.23
Cash from Financing 0.00
Net change in Cash -9.07
Free Cash Flow 21.90
Particulars MAR 2024 (Values in Cr)
Net Income 19.51
Cash from Operations 24.60
Cash from Investing -5.83
Cash from Financing 0.00
Net change in Cash 14.41
Free Cash Flow 30.68
Particulars MAR 2023 (Values in Cr)
Net Income 15.07
Cash from Operations 17.64
Cash from Investing -7.33
Cash from Financing 0.00
Net change in Cash 6.03
Free Cash Flow 25.27
Particulars MAR 2022 (Values in Cr)
Net Income 12.70
Cash from Operations 10.73
Cash from Investing -3.01
Cash from Financing -9.55
Net change in Cash -4.95
Free Cash Flow 13.94
Particulars MAR 2021 (Values in Cr)
Net Income 14.72
Cash from Operations 15.67
Cash from Investing 0.05
Cash from Financing 1.64
Net change in Cash 13.78
Free Cash Flow 20.72
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 30.98 13.41 1.60 237.41 23.12 40.44
BLISS GVS PHARMA LTD. 272.85 26.09 2.54 2886.45 114.45 285.05
CIPLA LTD 1292.00 21.95 3.17 104365.52 1165.55 1672.20
FERMENTA BIOTECH LIMITED 286.10 9.52 2.15 842.02 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2448.10 41.23 24.28 41472.29 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 30.98 29.79 4.31 237.41 23.12 40.44
AMRUTAJAN HEALTH LTD 556.10 24.93 4.34 1607.72 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8308.30 99.85 25.99 20770.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 272.85 37.17 2.61 2886.45 114.45 285.05

PAR DRUGS AND CHEM LTD shareholding pattern

Holding
26.59%
73.4%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

PAR DRUGS AND CHEM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
93.01 1.56 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 92.70
  • 26 Days 91.50
  • 10 Days 92.30
  • 50 Days 91.50
  • 12 Days 92.20
  • 100 Days 92.90
  • 20 Days 91.70
  • 200 Days 102.00
92.17 PIVOT
First Support 89.74 First Resistance 94.00 Second Support 87.91 Second Resistance 96.43 Third Support 85.48 Third Resistance 98.26
RSI 50.55 ADX 43.62 MACD 0.75 Williams % R -67.34 Commodity Channel Index (CCI) -16.86
Date 2026-05-12 Week 4293.00 Same Day 3450.00 Month 4081.00
1 Year 0.95 3 Year 0.83
Over 1 Month
0.50% down
Over 1 Year
-8.15% down
Over 3 Months
-8.28% down
Over 3 Years
-18.70% down
Over 6 Months
-6.20% down
Over 5 Years
8.46% down

PAR DRUGS AND CHEM LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
22 Nov 2021 1.25 Interim 23 Nov 2021 Equity shares
10 Jul 2020 1.25 Final 14 Jul 2020 Equity shares
22 Nov 2019 1.25 Interim 25 Nov 2019 Equity shares
Ex-Date Ex-Bonus Ratio
28 Apr 2021 27 Apr 2021 1:1

Top Gainers

Top Losers

PAR DRUGS AND CHEM LTD Share Price

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018.

The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani. The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business. With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets.

At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.

There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx. 9,700 MTPA. Block 1- APIs, Block 2- Magnesium Hydroxide, Block 3- Fine Chemicals and Block 4- APIs/ Fine Chemicals. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals.

The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited.

The Company raised money from public through IPO by issuing 16,72,000 Equity Shares aggregating to Rs 8.53 Crore in May, 2019.

In June, 2021, the Company started a set of new production line-up i.e. one new manufacturing block, which increases production capacity within the existing product portfolio i.e. same as per existing product portfolio and market. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx 9,700 MTPA. Block 1 - APls, Block 2 - Magnesium Hydroxide, Block 3 - Fine Chemicals and Block 4 - APls/ Fine Chemicals.

Parent organization Indian Private
NSE symbol PAR
Founded 1999
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Par Drugs & Chemicals Ltd?

Answer Field

Par Drugs & Chemicals Ltd share price is for NSE ₹ 93.25 & for BSE ₹ 0.00 as on May 13 2026 03:29 PM.

What is the Market Cap of Par Drugs & Chemicals Ltd Share?

Answer Field

The market cap of Par Drugs & Chemicals Ltd for NSE ₹ 114.40 & for BSE ₹ 0.00 as on May 13 2026 03:29 PM.

What is the 52 Week High and Low of Par Drugs & Chemicals Ltd?

Answer Field

The 52 Week High and Low of Par Drugs & Chemicals Ltd for NSE is ₹ 122.43 and ₹ 78.05 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Par Drugs & Chemicals Ltd?

Answer Field

The 1 year returns on the stock has been -8.15%.

What is the P/E Ratio of Par Drugs & Chemicals Ltd Share?

Answer Field

As on May 13 2026 03:29 PM the price-to-earnings (PE) ratio for Par Drugs & Chemicals Ltd share is 8.10.

What is the PB ratio of Par Drugs & Chemicals Ltd Share?

Answer Field

As on May 13 2026 03:29 PM, the price-to-book (PB) ratio for Par Drugs & Chemicals Ltd share is 86.49.

How to Buy Par Drugs & Chemicals Ltd Share?

Answer Field

You can trade in Par Drugs & Chemicals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Par Drugs & Chemicals Ltd Share on Bajaj Broking App?

Answer Field

To buy Par Drugs & Chemicals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Par Drugs & Chemicals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|